Ultraflux® AV 400S, 600S, and 1000S

Ultraflux® AV 400S, AV 600S, and AV 1000S are steam-sterilised haemofilters designed for Continuous Renal Replacement Therapy (CRRT). They are integral in managing acute renal failure, ensuring effective correction of electrolyte imbalance, acid/base metabolism, and the removal of urea and creatinine.

Features
  • Ultraflux® Series: Specifically engineered with Fresenius Polysulfone® membrane, capable of filtering substances up to 30,000 Dalton while retaining essential plasma proteins and blood components.
  • High Efficiency: Large inner lumen and thin capillary walls optimize fluid exchange, ultrafiltrate flow, and reduce flow resistance, ensuring prolonged filter lifespan.
  • Versatile Treatment Modes: Supports various CRRT modes including CAVH, CVVH, HV-CVVH, CVVHDF, CVVHD, and SCUF, tailored to patient conditions.
Benefits
  • Enhanced Patient Stability: Offers superior cardiovascular stability compared to intermittent therapies, crucial for hemodynamically unstable patients.
  • Blood Compatibility: Demonstrates excellent biocompatibility, minimizing coagulation risks and reducing the need for anticoagulants.
  • Sterilization Advantage: INLINE-steam sterilisation ensures a pyrogen-free product, eliminating toxic residues and reducing saline consumption.
Specifications
  • Membrane: Fresenius Polysulfone®
  • Surface Area: AV 400S (0.75 m²), AV 600S (1.4 m²), AV 1000S (1.8 m²)
  • Blood Flow: Recommended ranges from 50 to 500 ml/min depending on model
  • Filtrate Flow: Up to 20% of effective blood flow (postdilution)
  • Sterilisation: INLINE-Steam method, ensuring product safety and efficacy
Scroll to Top